256 related articles for article (PubMed ID: 22539604)
21. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations.
Wu C; Hu Z; Yu D; Huang L; Jin G; Liang J; Guo H; Tan W; Zhang M; Qian J; Lu D; Wu T; Lin D; Shen H
Cancer Res; 2009 Jun; 69(12):5065-72. PubMed ID: 19491260
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
23. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
24. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
[TBL] [Abstract][Full Text] [Related]
25. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
[TBL] [Abstract][Full Text] [Related]
26. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
27. Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics.
Nedeljkovic I; Carnero-Montoro E; Lahousse L; van der Plaat DA; de Jong K; Vonk JM; van Diemen CC; Faiz A; van den Berge M; Obeidat M; Bossé Y; Nickle DC; Consortium B; Uitterlinden AG; van Meurs JJB; Stricker BCH; Brusselle GG; Postma DS; Boezen HM; van Duijn CM; Amin N
Eur J Hum Genet; 2018 May; 26(5):709-722. PubMed ID: 29422661
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
[TBL] [Abstract][Full Text] [Related]
29. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.
Lan Q; Hsiung CA; Matsuo K; Hong YC; Seow A; Wang Z; Hosgood HD; Chen K; Wang JC; Chatterjee N; Hu W; Wong MP; Zheng W; Caporaso N; Park JY; Chen CJ; Kim YH; Kim YT; Landi MT; Shen H; Lawrence C; Burdett L; Yeager M; Yuenger J; Jacobs KB; Chang IS; Mitsudomi T; Kim HN; Chang GC; Bassig BA; Tucker M; Wei F; Yin Z; Wu C; An SJ; Qian B; Lee VH; Lu D; Liu J; Jeon HS; Hsiao CF; Sung JS; Kim JH; Gao YT; Tsai YH; Jung YJ; Guo H; Hu Z; Hutchinson A; Wang WC; Klein R; Chung CC; Oh IJ; Chen KY; Berndt SI; He X; Wu W; Chang J; Zhang XC; Huang MS; Zheng H; Wang J; Zhao X; Li Y; Choi JE; Su WC; Park KH; Sung SW; Shu XO; Chen YM; Liu L; Kang CH; Hu L; Chen CH; Pao W; Kim YC; Yang TY; Xu J; Guan P; Tan W; Su J; Wang CL; Li H; Sihoe AD; Zhao Z; Chen Y; Choi YY; Hung JY; Kim JS; Yoon HI; Cai Q; Lin CC; Park IK; Xu P; Dong J; Kim C; He Q; Perng RP; Kohno T; Kweon SS; Chen CY; Vermeulen R; Wu J; Lim WY; Chen KC; Chow WH; Ji BT; Chan JK; Chu M; Li YJ; Yokota J; Li J; Chen H; Xiang YB; Yu CJ; Kunitoh H; Wu G; Jin L; Lo YL; Shiraishi K; Chen YH; Lin HC; Wu T; Wu YL; Yang PC; Zhou B; Shin MH; Fraumeni JF; Lin D; Chanock SJ; Rothman N
Nat Genet; 2012 Dec; 44(12):1330-5. PubMed ID: 23143601
[TBL] [Abstract][Full Text] [Related]
32. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation.
Botling J; Edlund K; Lohr M; Hellwig B; Holmberg L; Lambe M; Berglund A; Ekman S; Bergqvist M; Pontén F; König A; Fernandes O; Karlsson M; Helenius G; Karlsson C; Rahnenführer J; Hengstler JG; Micke P
Clin Cancer Res; 2013 Jan; 19(1):194-204. PubMed ID: 23032747
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
34. Implications for powering biomarker discovery studies.
Dibben SM; Holt RJ; Davison TS; Wilson CL; Taylor J; Paul I; McManus K; Kelly PJ; Proutski V; Harkin DP; Kerr P; Fennell DA; James JA; Kennedy RD
J Mol Diagn; 2012; 14(2):130-9. PubMed ID: 22251612
[TBL] [Abstract][Full Text] [Related]
35. Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markers.
Yanagitani N; Kohno T; Kim JG; Kunitoh H; Tamura T; Takei Y; Tsuchiya S; Saito R; Yokota J
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):366-71. PubMed ID: 12692112
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC.
Timofeeva MN; McKay JD; Smith GD; Johansson M; Byrnes GB; Chabrier A; Relton C; Ueland PM; Vollset SE; Midttun Ø; Nygård O; Slimani N; Romieu I; Clavel-Chapelon F; Boutron-Ruault MC; Fagherazzi G; Kaaks R; Teucher B; Boeing H; Weikert C; Bueno-de-Mesquita HB; van Gils C; Peeters PH; Agudo A; Barricarte A; Huerta JM; Rodríguez L; Sánchez MJ; Larrañaga N; Khaw KT; Wareham N; Allen NE; Travis RC; Gallo V; Norat T; Krogh V; Masala G; Panico S; Sacerdote C; Tumino R; Trichopoulou A; Lagiou P; Trichopoulos D; Rasmuson T; Hallmans G; Riboli E; Vineis P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2250-61. PubMed ID: 21862624
[TBL] [Abstract][Full Text] [Related]
37. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
[TBL] [Abstract][Full Text] [Related]
38. AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status.
Falvella FS; Spinola M; Pignatiello C; Noci S; Conti B; Pastorino U; Carbone A; Dragani TA
Oncogene; 2008 Mar; 27(11):1650-6. PubMed ID: 17724461
[TBL] [Abstract][Full Text] [Related]
39. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
Tomiyasu M; Yoshino I; Suemitsu R; Okamoto T; Sugimachi K
Clin Cancer Res; 2002 Dec; 8(12):3755-60. PubMed ID: 12473586
[TBL] [Abstract][Full Text] [Related]
40. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
